Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer

The purpose of this study is to demonstrate the functionality of a novel endorectal photoacoustic ultrasound imaging modality in humans with rectal cancer. The study involves testing a previously developed endorectal device to determine its ability to accurately assess rectal tumor response to preoperative treatment. Investigators hypothesize that a co-registered photoacoustic ultrasound endorectal device can significantly reduce unnecessary surgeries in rectal cancer patients with complete clinical response while maintaining high sensitivity in identifying those with residual cancer.

Trial Details

NCT ID
NCT04339374
Phase
NA
Sponsor
Washington University School of Medicine
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • Photoacoustic imaging, photoacoustic microscopy
  • Endorectal photoacoustic imaging probe
  • Reader Performance
Locations (sample)
  • St Louis, Missouri, United States|38.62727,-90.19789

Key Eligibility Criteria

  • Patients with any stage of rectal cancer undergoing surgical resection.
  • Age \>18 years
  • Able to provide informed consent
  • Additional Inclusion Criterion for in vivo imaging (patients):

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →